Join        Login             Stock Quote

DaVita (DVA) Kidney Care Division In Drug Services Contract With Fresenius Medical Care

 January 08, 2013 01:51 PM

(By Balachander) DaVita HealthCare Partners Inc. (NYSE: DVA) said its kidney care division has agreed to provide certain pharmacy services to Fresenius Medical Care (FMC).

FMC, which offers dialysis services, will use DaVita Rx prescription drug services for its Medicare patients in the United States.

Congress required that beginning in 2011, some oral medications will be included in the bundled payment model. By 2016 all oral end stage renal disease medications will be included in the bundled payment.

FMC's contract with DaVita Rx will help implement that requirement by using DaVita Rx's pharmacy to fill and ship oral medications to FMC Medicare patients.

[Related -Japan Surges Near 5-Year Highs]

DaVita Rx pharmacy services for FMC will begin in late 2013.

In addition, DaVita said it will be extending its long-standing vendor relationship with FMC for certain dialysis supplies including hemodialysis machines and disposable products.

DaVita Rx has served the prescription drug needs of patients receiving dialysis from DaVita and other dialysis providers since 2005.

On Tuesday, DVA shares rose 0.76 percent to trade at $109.11.

iOnTheMarket Premium


Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageWatch This Alternative Investment for a Buy Signal

All major U.S. indices closed essentially unchanged last week except for the small-cap Russell 2000. While read on...

article imageUS REITs Edged Higher Last Week As Emerging Markets Slumped

Real estate investment trusts (REITs) in the US took the lead in last week’s shortened holiday trading week read on...

article imageA Contrarian Perspective On The Short EuroTtrade

As the euro continues to drift lower, it has become the accepted wisdom that we are headed for parity with read on...

article imageEmerging-Markets Stocks Took The Lead Last Week

Emerging-markets equities enjoyed a solid rise last week among the major asset classes, based on a set of read on...

Popular Articles

Daily Sector Scan
Partner Center

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.